ADA and hyperinsulinemic hypoglycemia, familial, 4: Manson et al. showed that unusual chondroosseous findings could be seen in patients with ADA deficiency and these anomalies would be resolved during 6–12 months of ADA enzyme replacement therapy when adenosine levels are back to normal [65].